Pricing Log in Create free account

Immunocore Holdings PLC Sponsored ADR (IMCR) vs Precigen, Inc. (PGEN)

Immunocore Holdings PLC Sponsored ADR and Precigen, Inc. are both Biotechnology companies. Immunocore Holdings PLC Sponsored ADR and Precigen, Inc. are of similar size ($1.5B and $1.5B). Immunocore Holdings PLC Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Precigen, Inc. trades at 60.3×. Precigen, Inc. grew revenue faster over the last twelve months: 2,387.6% against 13.1%. Precigen, Inc. has the higher net margin (15.6% vs −7.48%) and the higher return on invested capital (15.9% vs 0.00%). Across the 18 metrics below, Immunocore Holdings PLC Sponsored ADR leads on 9 and Precigen, Inc. on 9.

Valuation

Metric IMCR PGEN Biotechnology median
P/E n/m 60.27 10.60
P/S 3.71 10.11 9.40
P/B 3.80 18.94 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 43.41 0.66
EV/Sales 2.64 10.51 9.02
Earnings yield (2.06%) 1.66% (32.88%)
Free cash flow yield (1.14%) (4.68%) (23.13%)

Profitability

Metric IMCR PGEN Biotechnology median
Gross margin 98.86% 91.42% 68.51%
Operating margin (6.76%) 21.43% 0.00%
Net margin (7.48%) 15.55% 0.00%
Free cash flow margin (4.24%) (47.35%) 0.00%
Return on equity (7.87%) 38.84% (51.96%)
Return on assets (2.88%) 12.73% (46.06%)
Return on invested capital 0.00% 15.93% 0.00%

Growth

Metric IMCR PGEN Biotechnology median
Revenue growth (TTM) 13.10% 2,387.61% 6.76%
EPS growth (last fiscal year) 30.39% (191.49%) 29.88%
Revenue growth, 5-year CAGR 59.57% (21.26%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMCR PGEN Biotechnology median
Debt to equity 0.94 1.12 0.00
Current ratio 4.62 5.58 4.97
Net debt to EBITDA 11.19 0.04 1.01

Dividend

Metric IMCR PGEN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IMCR PGEN Biotechnology median
Market cap 1.46b 1.51b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack